Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Biological Sample Collection Aiming to Validate Non-invasive Prenatal Tests by Analyzing Fetal DNA Present in Maternal Blood Using a Next-generation Digital PCR Technique

NCT05618431 is registered in ClinicalTrials.gov with CerbaXpert as lead sponsor.

NCT NCT05618431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Biological Sample Collection Aiming to Validate Non-invasive Prenatal Tests by Analyzing Fetal DNA Present in Maternal Blood Using a Next-generation Digital PCR Technique
Lead sponsor
CerbaXpert
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2023
Completion date
June 1, 2024
Enrollment
1,790 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

validation of new test nipt